|
HY-126037-1mg
|
MedChemexpress LLC
|
(�)-ML 209 [CAS 1334526-14-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-116227-5mg
|
MedChemexpress LLC
|
(2S,3R)-LP99 [CAS 1808948-28-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-134950-1mg
|
MedChemexpress LLC
|
(E)-C-HDMAPP (ammonium) [CAS 933030-60-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-N2492-100mg
|
MedChemexpress LLC
|
(E)-Methyl 4-coumarate [CAS 19367-38-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-N2492-1mL
|
MedChemexpress LLC
|
(E)-Methyl 4-coumarate [CAS 19367-38-5] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-126390-1mg
|
MedChemexpress LLC
|
(E/Z)-BCI [CAS 15982-84-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-124257-10mg
|
MedChemexpress LLC
|
(R)-Citronellol [CAS 1117-61-9]
|
|
COVID-19-immunoregulation
|
|
|
HY-124257-100mg
|
MedChemexpress LLC
|
(R)-Citronellol [CAS 1117-61-9]
|
|
COVID-19-immunoregulation
|
|
|
HY-124257-5mg
|
MedChemexpress LLC
|
(R)-Citronellol [CAS 1117-61-9]
|
|
COVID-19-immunoregulation
|
|
|
HY-124257-50mg
|
MedChemexpress LLC
|
(R)-Citronellol [CAS 1117-61-9]
|
|
COVID-19-immunoregulation
|
|
|
HY-124257-1mL
|
MedChemexpress LLC
|
(R)-Citronellol [CAS 1117-61-9] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-N6937-10mg
|
MedChemexpress LLC
|
(R,R)-Secoisolariciresinol diglucoside [CAS 158932-33-3]
|
|
COVID-19-immunoregulation
|
|
|
HY-N6937-20mg
|
MedChemexpress LLC
|
(R,R)-Secoisolariciresinol diglucoside [CAS 158932-33-3]
|
|
COVID-19-immunoregulation
|
|
|
HY-N6937-5mg
|
MedChemexpress LLC
|
(R,R)-Secoisolariciresinol diglucoside [CAS 158932-33-3]
|
|
COVID-19-immunoregulation
|
|
|
HY-N6937-1mL
|
MedChemexpress LLC
|
(R,R)-Secoisolariciresinol diglucoside [CAS 158932-33-3] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-117917-10mg
|
MedChemexpress LLC
|
(Rac)-MGV354 [CAS 1852495-86-3]
|
|
COVID-19-immunoregulation
|
|
|
HY-117917-100mg
|
MedChemexpress LLC
|
(Rac)-MGV354 [CAS 1852495-86-3]
|
|
COVID-19-immunoregulation
|
|
|
HY-117917-25mg
|
MedChemexpress LLC
|
(Rac)-MGV354 [CAS 1852495-86-3]
|
|
COVID-19-immunoregulation
|
|
|
HY-117917-5mg
|
MedChemexpress LLC
|
(Rac)-MGV354 [CAS 1852495-86-3]
|
|
COVID-19-immunoregulation
|
|
|
HY-117917-50mg
|
MedChemexpress LLC
|
(Rac)-MGV354 [CAS 1852495-86-3]
|
|
COVID-19-immunoregulation
|
|
|
HY-N0608A-1mg
|
MedChemexpress LLC
|
(Rac)-Myrislignan [CAS 41535-95-9]
|
|
COVID-19-immunoregulation
|
|
|
HY-N0608A-5mg
|
MedChemexpress LLC
|
(Rac)-Myrislignan [CAS 41535-95-9]
|
|
COVID-19-immunoregulation
|
|
|
HY-120006A-10mg
|
MedChemexpress LLC
|
(rel)-AR234960 [CAS 1408311-94-3]
|
|
COVID-19-immunoregulation
|
|
|
HY-120006A-100mg
|
MedChemexpress LLC
|
(rel)-AR234960 [CAS 1408311-94-3]
|
|
COVID-19-immunoregulation
|
|
|
HY-120006A-5mg
|
MedChemexpress LLC
|
(rel)-AR234960 [CAS 1408311-94-3]
|
|
COVID-19-immunoregulation
|
|
